Dab tsi yog qhov kev ntsuas kev ntsuas ntawm COZING-USBN2 qis qis kev kho lub teeb liab?
|
Qauv nab npawb |
COZING-USBN2 |
|
Txoj kev kho: |
Nasal low light laser kho |
|
Laser wavelength: |
810nm laser kho apparatus |
|
Laser Penetration: |
5-7cm |
|
Yam Khoom Pob Dimension: |
15 * 15 * 10cm |
|
Tsim |
humanized |
|
Fais fab mov |
power bank, computer, xov tooj charger, thiab lwm yam. |
Dab tsi yog qhov qhia tau ntawm COZING-USBN2 qis qis kev kho lub teeb liab?
- Cerebrovascular Accident (Cva)
- Cerebral Blood Flow Thiab Cerebral Oxygen Supply
- Kev puas tsuaj ntawm lub paj hlwb
- Occlusive Cerebrovascular Disease
Dab tsi yog qhov zoo ntawm COZING-USBN2 low-level red light therapy?
Boasts USB interface, tso cai rau nws ua haujlwm ntawm nws tus kheej yam tsis tas yuav muaj kev sib txuas rau lub ntsiab chav tsev. Tsis tas li ntawd, nws tuaj yeem cuam tshuam nrog lub computer, lub txhab nyiaj fais fab, lossis adapter rau kev ua haujlwm.
COZING-USBN2 tuaj yeem txo cov kev siv tshuaj thiab txo cov kev mob tshwm sim los ntawm kev sib cuag ntawm lub cev nrog tshuaj.
Nws cov neeg siv-phooj ywg ua haujlwm kom yooj yim ntawm kev siv.
Nws compact thiab lub teeb yuag tsim txhim kho portability.
Tsuas ntsaws rau hauv, thiab cov zis laser yuav pib txiav.
COZING-USBN2 qis theem teeb liab kho zaub:
COZING-USBN2 low-level red light therapy ua haujlwm li cas?
Qhov ze Infrared low light laser wavelengths feem ntau nyiam rau kev kho cov ntaub so ntswg sib sib zog nqus xws li tsom rau lub hlwb.
Qhov tseem ceeb tshaj plaws yog tias 810nm yog qhov nyiam tshaj plaws wavelength rau transcranial Photobiomodulation (lub hom phiaj ntawm lub hlwb los ntawm lub taub hau) vim nws tau cog lus tias muaj qhov nkag mus tob tshaj plaws, raws li ib tsab xov xwm tshuaj xyuas rau tPBM muaj qhov no hais:
"Thaum peb tshawb xyuas qhov kev xaiv wavelength rau transcranial LLLT hauv SCI-indexed cov khoom thiab lwm cov ntawv tshaj tawm, peb pom tias feem ntau siv thiab kev txhawj xeeb wavelength yog 810 nm."
Lwm xyoo 2023 tshuaj xyuas tsab xov xwm ntawm transcranial photobiomodulation muaj qhov no los hais txog ib qho kev ua tau zoo ntawm kev noj tshuaj rau lub hlwb.
"Ib qho ntawm cov txheej txheem ntau tshaj plaws rau cov neeg siv tshuaj kho mob ua haujlwm cov khoom xa tawm ze-infrared teeb (810 nm), irradiance ntawm 20-25 mW / cm2, thiab fluence ntawm 1-10 J / cm2."
Cov quotes no lees paub qhov kev lag luam uas thaum 810nm cog lus tias qhov kev nkag mus zoo tshaj plaws ua rau nws nyiam rau cov hom phiaj transcranial, uas tseem ceeb heev rau cov txiaj ntsig ntawm lub hlwb.
COZING-USBN2 low-level red light therapy Clinical study:
Keeb Kwm thiab Lub Hom Phiaj: Lub tswv yim yog tias transcranial laser therapy (TLT) siv ze-infrared laser tshuab tuaj yeem kho mob stroke ischemic. Lub NeuroThera Kev Ua Tau Zoo thiab Kev Ntsuas Kev Nyab Xeeb-2 (NEST-2) txhawm rau ntsuas kev nyab xeeb thiab kev ua tau zoo ntawm TLT hauv cov ntsiab lus no.
Cov txheej txheem: Txoj kev tshawb no yog ob qhov muag tsis pom kev, randomized sim sib piv TLT kev kho mob rau kev tswj hwm kev txaj muag. Cov neeg mob uas tau txais cov ntaub so ntswg plasminogen activator lossis muaj pov thawj ntawm hemorrhagic infarct raug cais tawm. Thawj qhov ua tau zoo kawg nkaus tau ua tiav qhov txiaj ntsig zoo ntawm 0 rau 2 ntawm qhov hloov kho Rankin Scale ntawm 90 hnub. Cov ntsiab lus kawg ntxiv suav nrog tag nrho kev hloov pauv hauv Rankin Scale thiab kev hloov pauv hauv National Institutes of Health Stroke Scale (NIHSS) tau qhab nia dhau 90 hnub.
Cov txiaj ntsig: Tag nrho ntawm 660 cov neeg mob tau raug txheeb xyuas, nrog 331 tau txais TLT thiab 327 tau txais kev txaj muag. Hauv pawg TLT, 120 tus neeg mob (36.3%) tau ua tiav qhov txiaj ntsig zoo piv rau 101 tus neeg mob (30.9%) hauv pawg sham (P=0.094), ua rau muaj qhov sib txawv ntawm 1.38 (95% CI, 0.95 rau 2.{17}}). Cov txiaj ntsig zoo sib xws tau pom rau lwm qhov kev ntsuas tau tshwm sim. Txawm hais tias tsis muaj kev ntsuam xyuas ua ntej tau mus txog qhov tseem ceeb, kev soj ntsuam tom qab hoc ntawm cov neeg mob uas muaj qhov qhab nia NIHSS tsawg dua 16 tau pom qhov txiaj ntsig zoo ntawm 90 hnub ntawm thawj qhov kawg (P<0.044). Mortality rates (17.5% for TLT vs. 17.4% for sham) and serious adverse events (37.8% for TLT vs. 41.8% for sham) were comparable between the groups.
Cov lus xaus: TLT nyob rau hauv 24 teev ntawm kev mob stroke pib muaj kev nyab xeeb tab sis tsis ua tiav cov ntaub ntawv tseem ceeb rau kev ua tau zoo. Txawm li cas los xij, txhua qhov kev ntsuam xyuas ua ntej qhia tau hais tias muaj qhov zoo sib xws, zoo ib yam nrog cov txiaj ntsig los ntawm NEST yav dhau los -1 mus sib hais. Ob qhov kev tshawb fawb qhia tias TLT tsis cuam tshuam rau kev tuag lossis cov xwm txheej tsis zoo. Kev sim ua kom tiav nrog cov txheej txheem NIHSS cais tawm yog npaj.
FAQ
